3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
127
Neoplasm Metastasis
18
Ovarian Neoplasms
12
Endometrial Neoplasms
9
Neoplasms
8
Triple Negative Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
6
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Hereditary Sensory and Autonomic Neuropathies
5
Colorectal Neoplasms
5
Advanced Breast Cancer
5
Squamous Cell Carcinoma of Head and Neck
4
Stomach Neoplasms
3
Recurrence
3
Neoplasms by Site
3
Head and Neck Neoplasms
3
Carcinoma, Lobular
3
Breast Diseases
3
Breast Cancer Metastatic
3
Uterine Neoplasms
2
Small Cell Lung Carcinoma
2
Multiple Endocrine Neoplasia Type 1
2
Melanoma
2
Locally Advanced (Inoperable) or Metastatic Breast Cancer
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Advanced Solid Tumors
2
Urologic Neoplasms
1
Urogenital Neoplasms
1
Interventions
Specimen Handling
9
Tamoxifen
8
Radiotherapy
6
exemestane
3
Radiation Dose Hypofractionation
3
Radiation
3
Letrozole
3
Anastrozole
3
Surveys and Questionnaires
2
Sentinel Lymph Node Biopsy
2
Radiotherapy, Intensity-Modulated
2
Radiotherapy, Conformal
2
Patient Navigation
2
Observation
2
Metformin
2
Mastectomy
2
Magnetic Resonance Spectroscopy
2
Genetic Testing
2
Biopsy
2
trastuzumab biosimilar HLX02
1
ruxolitinib
1
poly ICLC
1
palbociclib
1
fezolinetant
1
elacestrant
1
afimoxifene
1
abemaciclib
1
Trastuzumab
1
Testosterone
1
Tablets
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Intraductal, Noninfiltrating
×
Fulvestrant
×
1 year
×
Clear all
No trials found.